NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,710,000 | +14.2% | 4,400,226 | +25.6% | 3.18% | +10.3% |
| Q2 2023 | $170,530,916 | +16.9% | 3,504,540 | +33.4% | 2.89% | +9.1% |
| Q1 2023 | $145,863,310 | -17.3% | 2,627,221 | -40.2% | 2.65% | -23.3% |
| Q4 2022 | $176,361,244 | +76.7% | 4,390,372 | +92.8% | 3.45% | +86.1% |
| Q3 2022 | $99,784,000 | +73.6% | 2,277,136 | +40.4% | 1.86% | +61.4% |
| Q2 2022 | $57,484,000 | +191.1% | 1,622,015 | +234.1% | 1.15% | +304.6% |
| Q1 2022 | $19,750,000 | – | 485,491 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |